ID: ALA3960170

Max Phase: Preclinical

Molecular Formula: C15H10N4O4

Molecular Weight: 310.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccccc1[N+](=O)[O-])[n+]1nn([O-])c2ccccc21

Standard InChI:  InChI=1S/C15H10N4O4/c20-15(10-9-11-5-1-2-6-12(11)19(22)23)17-13-7-3-4-8-14(13)18(21)16-17/h1-10H/b10-9+

Standard InChI Key:  FGIGZPJYRLBTLI-MDZDMXLPSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.27Molecular Weight (Monoisotopic): 310.0702AlogP: 1.93#Rotatable Bonds: 3
Polar Surface Area: 104.97Molecular Species: ACIDHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.80CX Basic pKa: CX LogP: -0.17CX LogD: -1.22
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.32Np Likeness Score: -0.72

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):